GW501516 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-19 and is reviewed periodically as new material appears.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Douyin (Chinese: 抖音; pinyin: Dǒuyīn; lit. 'Shaking Sound') was launched on 20 September 2016, by ByteDance, originally under the name A.me, before changing its name to Douyin in December 2016. Douyin was developed in nearly 7 months and within a year had 100 million users, with more than one billion videos viewed every day. While TikTok and Douyin share a similar user interface, the platforms operate separately. Douyin includes an in-video search feature that can search by people's faces for more videos of them, along with other features such as buying, booking hotels, and making geo-tagged reviews.
=== Source and biosynthesis === Valine, like other branched-chain amino acids, is synthesized by bacteria and plants, but not by animals. It is therefore an essential amino acid in animals, and needs to be present in the diet. Adult humans require about 24 mg/kg body weight daily. It is synthesized in plants and bacteria via several steps starting from pyruvic acid. The initial part of the pathway also leads to leucine. The intermediate α-ketoisovalerate undergoes reductive amination with glutamate. Enzymes involved in this biosynthesis include:
=== Electoral regulations === With 46 votes in favor, 50 against, and 28 abstentions, Congress approved the creation of a commission to investigate alleged electoral fraud in the 2021 Peruvian general election Allegations of electoral fraud were denied by the National Office of Electoral Processes, the National Jury of Elections, the OAS, the United States, and the European Union. Later, Congress green-lit a motion to change the electoral rules for the 2022 Peruvian municipal and regional elections. Because it is prohibited to modify electoral rules when the election is less than a year away, the Constitutional Committee has little time to pass new regulations. Previously, an attempt to suspend open primary elections for the 2022 regional and municipal elections failed, due to it only getting 45 votes in favor.
C-4 is very stable and insensitive to most physical shocks. C-4 cannot be detonated by a gunshot or by dropping it onto a hard surface. It does not explode when set on fire or exposed to microwaves. Detonation can be initiated only by a shockwave, such as when a detonator inserted into it is fired. When detonated, C-4 rapidly decomposes to release nitrogen, water and carbon oxides as well as other gases. The detonation proceeds at an explosive velocity of 8,092 m/s (26,550 ft/s). A major advantage of C-4 is that it can easily be molded into any desired shape to change the direction of the resulting explosion. C-4 has high cutting ability. For example, the complete severing of a 36-centimetre (14 in) deep I-beam takes between 680 and 910 g (1.50 and 2.01 lb) of C-4 when properly applied in thin sheets.
=== 1995–1996: Alice in Chains === While Alice in Chains was inactive during 1995, Staley joined the "grunge supergroup" Mad Season, which also featured Pearl Jam guitarist Mike McCready, bassist John Baker Saunders from The Walkabouts, and Screaming Trees drummer Barrett Martin. Mad Season released one album, Above, for which Staley provided lead vocals and the album artwork. The album spawned a number two Mainstream Rock chart single, "River of Deceit", and a home video release of Live at the Moore. In April 1995, Alice in Chains entered Bad Animals Studio in Seattle with producer Toby Wright, who had previously worked with Corrosion of Conformity and Slayer. While in the studio, an inferior version of the song "Grind" was leaked to radio, and received major airplay. On October 6, the band released the studio version of the song to radio via satellite uplink to stem the excessive spread of taped copies of the song. On November 7, 1995, Columbia Records released their self-titled album, Alice in Chains, which debuted at number one on the Billboard 200 and has since been certified triple platinum. Of the album's four singles, "Grind", "Again", "Over Now", and "Heaven Beside You", three feature Cantrell on lead vocals.
Sources: en.wikipedia.org
=== Tempe semangit === In Indonesia, ripe tempeh (two or more days old) is considered a delicacy. Names include tempe semangit ('stinky tempeh') in Java, hampir busuk ('almost rotten') tempeh or tempe kemarin ('yesterday tempeh'). Having a slightly pungent aroma, small amounts are used as a flavoring agent in traditional Javanese sayur lodeh vegetable stew and sambal tumpang.
However, some in the Japanese archaeological community remain skeptical about the presence of cattle in Japan during the Yayoi period, and there is a persistent view that they were brought to Japan from the Korean peninsula by the toraijin, a group of people who came to Japan in the mid-5th century during the Kofun period. At the Nango-Ōhigashi site in Gose City, Nara Prefecture, excavations revealed cow bones believed to date back to the 5th century. At the Funamiya Kofun Tumulus (late 5th century) in Asago City, Hyōgo Prefecture, pieces of a cow-shaped haniwa (clay figurine), believed to be the oldest in Japan, have been excavated. In addition, a cow-shaped haniwa was excavated from the Hashida No. 1 Tumulus in Tawaramoto Town, Shiki-gun, Nara Prefecture in the first half of the 6th century, and was designated as an Important Cultural Property of Japan in 1958. On the other hand, recent genetic studies have shown that Wagyu and Korean cattle (Hanwoo and others) differ greatly in their genetic information. Livestock cattle are divided into two major lineages: northern lineage cattle (Bos taurus) and Indian lineage cattle (Bos indicus), and both Wagyu and Korean cattle belong to the northern lineage and do not contain Indian lineage such as Zebu cattle. However, in terms of mitochondrial DNA haplogroups, haplogroup T4 (East Asian type) is predominant in the Wagyu (Japanese Black) at about 65%, while haplogroup T3 (European type) is predominant in Korean cattle at 66–83%.
Since then, the species name Naja/Hoplocephalus bungaroides, originally coined for the king cobra and improperly assigned to the broad-headed snake, became conflated with the broad-headed snake and used as the type species of Hoplocephalus, while the species name Naja bungarus was treated as a junior synonym of the king cobra (until its revival as the species name for the Sunda king cobra in 2024). This longstanding discrepancy, which breaks the principle of priority, was overlooked for nearly two centuries and only discovered in 2024. Due to the long presence of the names Ophiophagus hannah and Hoplocephalus bungaroides in the literature, which would be upended if these two species were reclassified based on this issue, it was decided to maintain the longstanding scientific names for both taxa and designate a new, accurate type specimen for the broad-headed snake.
Chromatographic methods with fluorescence detection Liquid chromatography with fluorescence detection (LC-FLD) provides a selective, relatively cheap, reproducible method for the qualitative and quantitative analysis of YTX for shellfish and algae samples. This method requires an additional sample preparation step after the analyte extraction procedure has been completed (in this case SPE is preferentially used so common interferences can be removed from the sample). This additional step involves the derivatization of the YTXs with a fluorescent dienophile reagent — dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalinyl)ethyl]-1,2,4-triazoline-3,5-dione, which facilitates analyte detection. This additional sample preparation step can make LC-FLD analysis extremely time-consuming and is a major disadvantage of the technique.
Under her leadership, the Thai government has advanced plans to legalize casinos as part of a broader initiative to develop large-scale "entertainment complexes". The policy is intended to attract foreign investment, stimulate tourism, create employment opportunities, and formalize Thailand's widespread underground gambling industry to increase government revenue. Paetongtarn has emerged as a prominent proponent of the initiative, presenting it as a strategy to develop "man-made" tourist destinations and enhance the country's global competitiveness. She has publicly argued that the project will stimulate the economy without using taxpayer funds, as the massive investment required (estimated at THB 100 billion per complex) will come from the private sector. The government projects that the complexes could boost GDP, increase tourist arrivals, and generate between 12 and 40 billion baht in annual tax revenue. In January 2025, the Thai cabinet approved the Entertainment Complex Bill in principle, providing a legal framework for the proposed developments. The bill outlines the creation of multiple integrated resort projects, incorporating five-star hotels, shopping centres, concert venues, theme parks, and other entertainment facilities. The legislation stipulates that casino operations must be limited to no more than 10 per cent of the total floor area of each complex. The policy has faced opposition from civic and religious groups, who warn of potential negative social consequences such as increased crime and gambling addiction.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.